Miriam Harris, MD, MSc

Assistant Professor, Boston University Chobanian & Avedisian School of Medicine

Biography

Dr. Harris is an Assistant Professor of Medicine at Chobanian and Avedisian School of Medicine and an addiction expert at Boston Medical Center. A graduate of McMaster University School of Medicine, Internal Medicine Residency at the University of British Columbia, General Internal Medicine Fellowship and Masters of Epidemiology at McGill University, and Addiction Medicine Fellowship at Boston University, Dr. Harris is passionate about women's health and harm reduction. Her research interests focus on the intersection of women’s health and substance use including increasing sexual, reproductive, and HIV prevention services in substance use treatment spaces, substance use treatment while pregnant and parenting, and gender-responsive harm reduction.

Clinically, she provides community-based methadone treatment at HCRC Bradston in Boston and attends on the General Medicine units and the Addiction Consult Service at Boston Medical Center.

Publications

  • Published 11/20/2025

    Bagley SM, Maschke AD, Harris MTH, Walley AY, Johnson S, Hurstak E, Farley J, Keller SG, McMahan VM, Barrett C, Coffin PO, Gunn CM. A qualitative study exploring motivations for participating in research among women who use opioids. PLoS One. 2025; 20(11):e0336061. PMID: 41264582.

    Read at: PubMed

  • Published 11/10/2025

    Ogden SN, Dichter ME, Major E, Harris MTH, Haley DF, Shafer PR, Clark JA. Women's Perspectives on the Influence of Intimate Partner Violence on Substance Use Disorder Recovery and Associated Service Needs. Womens Health Issues. 2026; 36(1):70-78. PMID: 41219018.

    Read at: PubMed

  • Published 10/30/2025

    Chatterjee A, Chase RP, Chahine RA, Davis J, Dsouza N, Ellison S, Bagley SM, Fisher T, Glasgow L, Harris MTH, Huang TT, Holloway J, Lounsbury DW, Oga E, Asman K, Roberts SM, Sabounchi N, Surratt HL, Lines LM, Stadler HW, Taylor JL, Davis A. Local level of social inequity moderates implementation of evidence-based practices tailored to minoritized populations to reduce opioid overdose deaths. J Subst Use Addict Treat. 2026 Jan; 180:209828. PMID: 41175975.

    Read at: PubMed

  • Published 9/2/2025

    Hall ME, Glasgow L, Holloway J, Chahine RA, Davis J, Harris MTH, Knudsen HK, Neufeld JL, Oga E, Lounsbury DW, Sabounchi N, Davis A, Smith M, Chase RP, Ellison SA, Harness J, Surratt HL, Walsh SL, Nakayima PJ, Chandler R. Reach of Community-Selected Strategies to Reduce Opioid-Related Overdose Deaths in the HEALing Communities Study. Subst Use Misuse. 2026; 61(2):200-208. PMID: 40892527.

    Read at: PubMed

  • Published 8/5/2025

    Abruzzo AR, Harris MTH, Sroussi HY, Suzuki J, Kass JI, Rettig EM. Oral cavity cancer after sublingual buprenorphine use. Oral Oncol. 2025 Sep; 168:107573. PMID: 40769054.

    Read at: PubMed

View All 31 Publications:   View Full Profile in BUMC

Websites

Education

  • McMaster University, MD

View all profiles